The authors assessed the role of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (FDG) in differentiation of benign from malignant focal pulmonary abnormalities seen on chest radiographs. Fifty-one patients underwent FDG PET scanning. Focal abnormalities at radiography included solitary pulmonary nodules (n = 38), pulmonary masses (n = 5), and poorly marginated infiltrates or opacities (n = 8). Proof of diagnosis was obtained by means of transbronchial biopsy (n = 21), open lung biopsy ( = 14), percutaneous needle biopsy (n = 14), or cytologic evaluation of sputum (n = 1). A nodule in one patient had been radiographically stable for at least 8 years. Quantitative analysis was performed by calculation of a standardized uptake ratio (SUR). Thirty-three malignant lesions had a mean SUR (± 1 standard deviation) of 6.5 ± 2.9. Eighteen benign lesions had a mean SUR of 1.7 ± 1.2. For a benign lesion with SUR of 2.5 or less, specificity of FDG PET was 100%, while sensitivity was 89%. These results suggest that FDG PET is accurate in differentiation of benign from malignant focal pulmonary abnormalities.
- Emission CT (ECT), 610.12163
- Lung neoplasms, diagnosis, 60.12163, 60.31, 60.321, 60.3221
- Lung neoplasms, radionuclide studies, 60.12163
- Lung, nodule, 60.28, 60.3221
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging